Canopy Growth Corp - Asset Resilience Ratio
Canopy Growth Corp (CGC) has an Asset Resilience Ratio of 0.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CGC total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Canopy Growth Corp's Asset Resilience Ratio has changed over time. See Canopy Growth Corp net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Canopy Growth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Canopy Growth Corp worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.03 Million | 0.45% |
| Total Liquid Assets | $5.03 Million | 0.45% |
Asset Resilience Insights
- Limited Liquidity: Canopy Growth Corp maintains only 0.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Canopy Growth Corp Industry Peers by Asset Resilience Ratio
Compare Canopy Growth Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 9.09% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.02% |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
Annual Asset Resilience Ratio for Canopy Growth Corp (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Canopy Growth Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 1.92% | $17.66 Million | $917.70 Million | -0.63pp |
| 2024-03-31 | 2.55% | $33.16 Million | $1.30 Billion | -1.78pp |
| 2023-03-31 | 4.33% | $105.53 Million | $2.44 Billion | -6.30pp |
| 2022-03-31 | 10.63% | $595.65 Million | $5.61 Billion | -6.42pp |
| 2021-03-31 | 17.04% | $1.16 Billion | $6.82 Billion | +6.91pp |
| 2020-03-31 | 10.13% | $488.19 Million | $4.82 Billion | -13.16pp |
| 2019-03-31 | 23.30% | $2.03 Billion | $8.73 Billion | +23.25pp |
| 2018-03-31 | 0.05% | $664.00K | $1.44 Billion | +0.05pp |
| 2017-03-31 | 0.00% | $0.02 | $677.61 Million | -- |
| 2016-03-31 | 0.00% | $0.00 | $143.36 Million | -- |
| 2015-03-31 | 0.00% | $356.86 | $47.77 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $25.96 Million | -- |
About Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such… Read more